ISB News

Mining Sewage To Track Population Health

Everybody pees and poops. So, what if there was a way to harness sewage to understand the general health of a population? 

That is exactly what Dr. Eric Alm is pursuing. Alm delivered the keynote speech — “Population-Scale COVID-19 Tracking Using Data Collected from Sewage” — in a live stream event put on by ISB and Town Hall Seattle. Alm discussed the promise of this novel form of public health tracking, and then joined ISB Assistant Professor Dr. Sean Gibbons for a Q&A conversation. 

Watch the video and Q&A here

Alm is a microbiome researcher and MIT professor, and the co-founder and scientific director of Biobot Analytics. Biobot collects the valuable information in waste water, analyzes it, and shares ways of leveraging that information to make cities healthier.

The ISB-Town Hall event was the public-facing precursor to ISB’s virtual course and symposium on the microbiome and its future role in precision medicine. The two-day event takes place October 15-16, and is called “Harnessing Our Inner Ecology To Track and Treat Disease.” It is free, and is intended for graduate students, postdoctoral fellows, principal investigators, industry scientists, educators, and clinicians from across the globe. Register for this event here

ISB and Town Hall Seattle Team Up

This virtual event is one of many being offered this year thanks to a partnership between Town Hall Seattle and ISB. In addition, we have a four-part 2020 speaker series highlighting some of the most important topics in science and health care. 

Future events will focus on brain health (October 20, 2020 at 6 p.m. PT with keynote Dr. David Eagleman) and AI in health care (November 5, 2020 at 6 p.m. PT with keynote Ellen Ullman). Please visit our speaker series events page for more information.

Throughout 2020, ISB is celebrating our 20th anniversary. Genomics pioneer Dr. Lee Hood co-founded ISB in 2000. We are a non-profit 501(c)3 biomedical research organization based in Seattle’s South Lake Union neighborhood.

Recent Articles

  • Drs. Naeha Subramanian, Leah Rommereim Gilmore, and Ajay Suresh Akhade

    Small, Persistent Increase in the Expression of NOD1 May Promote Cancer Risk

    ISB researchers have found that a small, persistent increase in the expression of NOD1 could be responsible for higher cancer risks. The research team found that a slight 1.5-fold uptick in NOD1 expression can activate the protein and downstream signaling pathways in a manner similar to vast (30- to 200-fold) overexpression.

  • CRI iAtlas

    CRI iAtlas Expands to Interactive Analysis of Data on Immunotherapy Treatments

    CRI iAtlas is a comprehensive web-based resource that allows oncologists and researchers to study and analyze interactions between tumors and the immune microenvironment. The iAtlas team released immuno-oncology modules that allow investigators to access and work with genomics data from trials of treatment with immune-checkpoint inhibitors.

  • Last-Minute Gift Ideas: 2020 Edition

    Wait, what day is it? What month is it? This year has been a doozy. The pandemic has fundamentally changed our lives, and at times, has made us feel like we’re in a real-life Groundhog Day. Well, if you’ve found yourself in the last-minute shopping scramble, we’re back with a half dozen solid ideas that we hope will make your gift-giving life easier.